Clinical Trial Update: Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision Algorithm

View source ↗

Summary

The trial evaluating the XAPPORT decision-support app for managing anticoagulation in patients treated with rivaroxaban undergoing elective surgery has been wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Atrial Fibrillation, Venous Thromboembolism | Status: WITHDRAWN